scholarly journals [18F]FEBMP: Positron Emission Tomography Imaging of TSPO in a Model of Neuroinflammation in Rats, and in vitro Autoradiograms of the Human Brain

Theranostics ◽  
2015 ◽  
Vol 5 (9) ◽  
pp. 961-969 ◽  
Author(s):  
Anjani K. Tiwari ◽  
Bin Ji ◽  
Joji Yui ◽  
Masayuki Fujinaga ◽  
Tomoteru Yamasaki ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Human Brain ◽  
Positron Emission Tomography Imaging ◽  
Emission Tomography ◽  
Tomography Imaging ◽  
Positron Emission

A Uniquely Modified DKL-based Peptide Probe for Positron Emission Tomography Imaging

2019 ◽  
Vol 25 (1) ◽  
pp. 96-103
Author(s):  
Yi Liu ◽  
Zhengjie Wang ◽  
Xiang Li ◽  
Fei Kang ◽  
Xiaowei Ma ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Positron Emission Tomography Imaging ◽  
Emission Tomography ◽  
Tomography Imaging ◽  
Positron Emission ◽  
Imaging Results ◽  
Gallium 68 ◽  
Tumor Selective

Peptides containing the asparagine-glycine-arginine (NGR) motif can target the tumor neovascular biomarker CD13/aminopeptidase N receptor. D-K6L9 is a tumor-selective anti-cancer peptide. To improve the capacity of NGR peptides to target tumors, we joined the NGR and D-K6L9 peptides to form NKL. Next, we linked 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) to NKL and labeled it with gallium 68 (68Ga, t1/2 = 67.7 min) to form 68Ga-DOTA-NKL. This novel probe was characterized in vitro. 68Ga-DOTA-NKL was stable in phosphate buffered saline at room temperature and in human serum at 37°C. We determined that the uptake rate of 68Ga-DOTA-NKL in CD13 receptor-positive 22Rv1 tumor cells was 3.15% ± 0.04 after 2 h, and tested 68Ga-DOTA-NKL using positron emission tomography (PET)/computed tomography imaging in vivo. MicroPET imaging results revealed that 22Rv1 tumor uptake of 68Ga-DOTA-NKL was 8.69 ± 0.20, 6.61 ± 0.22, 3.85 ± 0.06, and 1.41 ± 0.23 percentage injected dose per gram of tissue (%ID/g) at 0.5, 1, 2, and 3 h postinjection (pi), respectively. The tumor-to-background contrast in the subcutaneous human prostate cancer 22Rv1 mouse model was 9.97 ± 1.90. The 68Ga-DOTA-NKL probe has combined tumor-targeting and tumor-selective properties, and may be used to diagnose CD13-positive tumors.

scholarly journals Synthesis of a DOTA-C-glyco bifunctional chelating agent and preliminary in vitro and in vivo study of [68Ga]Ga-DOTA-C-glyco-RGD

RSC Advances ◽  
2021 ◽  
Vol 11 (13) ◽  
pp. 7672-7681
Author(s):  
Floriane Mangin ◽  
Charlotte Collet ◽  
Valérie Jouan-Hureaux ◽  
Fatiha Maskali ◽  
Emilie Roeder ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Cancer Diagnosis ◽  
Positron Emission Tomography Imaging ◽  
Chelating Agent ◽  
Emission Tomography ◽  
Tomography Imaging ◽  
Bifunctional Chelating Agent ◽  
Positron Emission

A carbohydrate containing [68Ga]Ga-DOTA-RGD tracer was designed and demonstrated promising results for cancer diagnosis by positron emission tomography imaging.

Aquaporin-4 Positron Emission Tomography Imaging of the Human Brain: First Report

2012 ◽  
Vol 23 (2) ◽  
pp. 219-223 ◽  
Author(s):  
Yuji Suzuki ◽  
Yukihiro Nakamura ◽  
Kenichi Yamada ◽  
Vincent J. Huber ◽  
Mika Tsujita ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Human Brain ◽  
Positron Emission Tomography Imaging ◽  
Aquaporin 4 ◽  
Emission Tomography ◽  
Tomography Imaging ◽  
First Report ◽  
Positron Emission

Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652

Synapse ◽  
1995 ◽  
Vol 20 (1) ◽  
pp. 37-43 ◽  
Author(s):  
Zsolt Szabo ◽  
Pan Fu Kao ◽  
Ursula Scheffel ◽  
Makiko Suehiro ◽  
William B. Mathews ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Human Brain ◽  
Positron Emission Tomography Imaging ◽  
Emission Tomography ◽  
Serotonin Transporters ◽  
Tomography Imaging ◽  
Positron Emission
Sign in / Sign up

Export Citation Format

Share Document